CODIMAL-L.A. 12 Drug Patent Profile
✉ Email this page to a colleague
When do Codimal-l.a. 12 patents expire, and when can generic versions of Codimal-l.a. 12 launch?
Codimal-l.a. 12 is a drug marketed by Schwarz Pharma and is included in one NDA.
The generic ingredient in CODIMAL-L.A. 12 is chlorpheniramine maleate; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; pseudoephedrine hydrochloride profile page.
Summary for CODIMAL-L.A. 12
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CODIMAL-L.A. 12 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CODIMAL-L.A. 12
US Patents and Regulatory Information for CODIMAL-L.A. 12
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schwarz Pharma | CODIMAL-L.A. 12 | chlorpheniramine maleate; pseudoephedrine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018935-001 | Apr 15, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |